GLI1 and neoplasm: In conclusion, the current study illustrated that the Shh/Gli1 pathway is aberrantly activated in GC, and the overactivation of the Shh/Gli1 pathway is associated with a higher aggressive tumor phenotype and a poorer prognosis of patients with GC.